View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Andreas Johannessen
  • Andreas Johannessen

Infront - New M&A transaction partly funded with equity

Infront to acquire Swiss-based Assetmax Stable revenues and improved underlying margins Trading too tight compared with peers, in our view

Andreas Johannessen
  • Andreas Johannessen

Infront - Time to show us some deleveraging

No deleveraging during Q1 – net leverage stayed at 5.4x Strategy focus will hopefully spur earnings growth ahead We stick to our view that the bond is too tightly priced

Andreas Johannessen
  • Andreas Johannessen

Infront - Nothing new under the sun

Somewhat higher leverage ratio vs. post-issue Stable outlook for revenues in 2022 Bond to follow general market movements

Eirik Thune Øritsland ... (+3)
  • Eirik Thune Øritsland
  • Jonas Bru Lien
  • Øystein Elton Lodgaard

Infront - Terminating coverage

ABG Sundal Collier terminates coverage of Infront BUY is our final recommendation NOK 38 is our final target price

Andreas Johannessen
  • Andreas Johannessen

Infront - No rocking of the boat

Beat due to non-recurring and volume-based revenues Partial payment of the SSRCF down to EUR 5m Net leverage of 4.6/4.9x on adjusted/reported EBITDA

Aksel Øverland Engebakken ... (+3)
  • Aksel Øverland Engebakken
  • Eirik Thune Øritsland
  • Øystein Elton Lodgaard

Infront - Building a house one brick at a time

Continuing to execute on strategy ‘21e EBITA up ~10% on continued synergy confidence BUY recommendation intact; TP nudged up to NOK 38 (37)

Aksel Øverland Engebakken ... (+4)
  • Aksel Øverland Engebakken
  • Bengt Jonassen
  • Casper Blom
  • Lukas Daul

Talking Points - AP Møller Maersk: Stronger for longer

EBITDA up 14% for 2021e, and 1% for 2022e Target price up to DKK 15,500 (14,100) – BUY

Andreas Johannessen
  • Andreas Johannessen

Infront - Higher margin and growth on the agenda

Strong EBITDA mainly from lower costs in the quarter Net leverage down to 6.1x on higher trailing EBITDA Long-term ambitions well above our assumptions

Aksel Øverland Engebakken ... (+3)
  • Aksel Øverland Engebakken
  • Eirik Thune Øritsland
  • Øystein Elton Lodgaard

Infront - Good underlying development Q-o-Q in Q3

Adj. EBITDA EUR 5.8m, 1m est. beat driven by consulting sales P&L synergy realization continues EUR +0.4m increase q-o-q Expect small positive estimate revisions on EBITDA for 21e

Aksel Øverland Engebakken ... (+2)
  • Aksel Øverland Engebakken
  • Martin Kaland

Talking Points - Salmones Camanchaca (Buy): Short-term margin pressure...

Challenging quarters ahead due to low prices Large discount to Norwegian peers, reiterate BUY

Andreas Johannessen
  • Andreas Johannessen

Infront - Beat on sales, but negative cash flow

Soft cash flow - net leverage still aggressive at 6.9x Successful cross-selling with deal wins in the quarter We find more attractive risk/reward elsewhere

Aksel Øverland Engebakken ... (+3)
  • Aksel Øverland Engebakken
  • Eirik Thune Øritsland
  • Øystein Elton Lodgaard

Infront - Reassuring Q2 makes the case for patience

Q2 showed resilience and mgmt. ability to execute on case ‘22e adj. EBITDA up 12% on higher synergies Peer pricing indicates NOK 50+: BUY

Aksel Øverland Engebakken ... (+3)
  • Aksel Øverland Engebakken
  • Eirik Thune Øritsland
  • Øystein Elton Lodgaard

Infront - Q2 can likely hike confidence in synergy case

Adj. EBITDA EUR 5m small underlying increase q-o-q Integration of Vwd acquisition continues to progress well Small net estimate changes expected post results

Aksel Øverland Engebakken ... (+7)
  • Aksel Øverland Engebakken
  • Bengt Jonassen
  • Casper Blom
  • Edvard Hagman
  • Erik Moberg
  • Laurits Kjærgaard
  • Lukas Daul

Talking Points - MTG (Buy): Media rights potential not to be ignored

H+H International (Buy) Post-results: UK lockdown is bad, but the only current risk …offering an option worth SEK 103/share BUY with target price of SEK 128 (124)

Aksel Øverland Engebakken
  • Aksel Øverland Engebakken

Infront - Synergy savings starting to materialise

Integration and synergy case are progressing well Adj. EBITDA down 4% for ’21e Reiterate BUY, TP NOK 34 (36)

Andreas Johannessen
  • Andreas Johannessen

Infront - The bond recovered to par level prematurely

Soft EBITDA translates into aggressive leverage of 6.9x EUR 0.9m incremental cost savings secured q-o-q The risk/reward is not appealing at the indicated levels

Aksel Øverland Engebakken
  • Aksel Øverland Engebakken

Infront - Solid outlook for rest of 20e

Q1 Sales in line, but adj. EBITDA -10% Confident wrt. to Covid ’19 resilience and integration work Small negative ‘21e EBITDA revisions

Infront ASA: 3 directors bought

Three Directors at Infront ASA bought 25,000 shares at between 15.700NOK and 15.900NOK. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the ...

Aksel Øverland Engebakken
  • Aksel Øverland Engebakken

Infront - Recent acquisition proved itself in Q4

The German acquisition delivered a solid Q4 Negative revisions in “old Infront”, but higher synergies Reiterate BUY: TP of NOK 36 (37)

Aksel Øverland Engebakken ... (+2)
  • Aksel Øverland Engebakken
  • Laurits Kjærgaard

Talking Points - Infront (Buy): Recent acquisition proved itself in Q4

Negative revisions in “old Infront”, but higher synergies Reiterate BUY: TP NOK 36 (37)

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch